Author

Angela De Leon

Dana-Farber/Boston Children's Cancer and Blood Disorders Center

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Approach:statistical model· 1 Assay:whole-genome sequencing· 1

Frequent Co-Authors

A. A. SmithiD· 1 shared Alberto PïccaiD· 1 shared Amy B. CameroniD· 1 shared April Ann ApfelbaumiD· 1 shared Bhavyaa ChandaranaiD· 1 shared Claudia L. KleinmaniD· 1 shared Connor C. BossiiD· 1 shared Cornelis Martinus van TilburgiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. A. SmithORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

A diverse landscape of FGFR alterations and co-mutations defines novel therapeutic strategies in pediatric low-grade gliomas

April Ann Apfelbaum, Eric Morin, Dominik Sturm, Georges Ayoub, Jeromy J. Digiacomo, Sher Bahadur, Bhavyaa Chandarana, Phoebe Power, Margaret M. Cusick, Dana Novikov, Prem Prabhakar, Robert E. Jones, Jayne R. Vogelzang, Connor C. Bossi, Seth W. Malinowski, , Pratiti Bandopadhayay

This study identifies FGFR alterations in pediatric gliomas, their association with specific histologies, and their response to targeted therapies.

Nature Communications · Jul 31, 2025Peer-reviewedCancer Biology